SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XILLIX FDA APPROVED

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: burner who wrote (308)9/9/1998 11:42:00 PM
From: Garry K.  Read Replies (1) of 572
 
It looks like the 1.2mill cross was from an institutional investor. I spoke with IR this morning, and they seem to think this certainly was the case.

IMO I think there has been several institutional fund managers (especially small mutual funds under 100 million) who have been forced to liquidate positions to meet redemptions in this market.If you have a small fund predominately in small cap companies, it is very unlikely in many cases that the manager is able to have a significant cash position to act as a buffer to meet redemption obligations during periods of high volatility. This scenerio may have been what we saw yesterday. Any comments?

I asked Laurie if there has been any negative developments. The only developments she could think of is the company has its strongest cash position ever, development of the LIFE applications are progressing smoothly, and sales continue to develop. My question is..... how does the market valuate this company at a market cap under $24 million?

Wish I could have come up with the cash to snap up 1.2million @ .75! Guess I will have to look at a smaller block:)

Good luck

Garry
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext